NCT04988555 2025-04-02
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
Sumitomo Pharma America, Inc.
Phase 1/2 Recruiting
Clinical Trials
1 trialsPrecursor Cell Lymphoblastic Leukemia-Lymphoma × gilteritinib × Other hematologic neoplasm × Clear all